Shuang Yan

188 Shizi Street
Suzhou, 215006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma

Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: March 18, 2026

A novel triple-knockout allogeneic BCMA CAR T-cell therapy (CT0590) for multiple myeloma: preclinical and phase 1 study.

A novel triple-knockout allogeneic BCMA CAR T-cell therapy (CT0590) for multiple myeloma: preclinical and phase 1 study.

Journal: Blood

Published: October 17, 2025

Long-term follow-up of zevor-cel in patients with relapsed/refractory multiple myeloma.

Long-term follow-up of zevor-cel in patients with relapsed/refractory multiple myeloma.

Journal: Blood advances

Published: June 12, 2025

Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main clone.

Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main clone.

Journal: British journal of haematology

Published: March 16, 2025

Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myeloma.

Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myeloma.

Journal: Scientific reports

Published: December 28, 2024

A 2D-STI echocardiographic diagnostic model established for cardiac amyloidosis complicated with multiple myeloma.

A 2D-STI echocardiographic diagnostic model established for cardiac amyloidosis complicated with multiple myeloma.

Journal: International journal of cardiology

Published: November 28, 2024

Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma

Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: April 25, 2024

Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma.

Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma.

Journal: Discover oncology

Published: January 04, 2024

The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients.

The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients.

Journal: Frontiers in oncology

Published: July 25, 2023

Autologous stem cell transplantation in multiple myeloma patients with renal impairment.

Autologous stem cell transplantation in multiple myeloma patients with renal impairment.

Journal: Annals of hematology

Published: August 26, 2022

The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients.

The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients.

Journal: Frontiers in oncology

Published: May 07, 2022

The Effects of Chidamide Combined with Anti-myeloma Drugs on the Proliferation and Apoptosis of Myeloma Cells

The Effects of Chidamide Combined with Anti-myeloma Drugs on the Proliferation and Apoptosis of Myeloma Cells

Journal: Zhongguo shi yan xue ye xue za zhi

Published: August 07, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026